Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 2/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 2/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30098629 | 1.00 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL738596 | 0.86 | MAPT (0.52) | NCF1LOXL2MAPTKDM4EALDH1A1 | |
| SCHEMBL28307763 | 0.85 | NCF1 (0.39) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL15947627 | 0.83 | NCF1 (0.54) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL21858489 | 0.79 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL6102087 | 0.79 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL1160101 | 0.79 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL3090736 | 0.79 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL828123 | 0.79 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A | |
| SCHEMBL29619912 | 0.79 | NCF1 (0.50) | NCF1LOXL2HTR1AADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115650816-A | Method for synthesizing 1, 3-diacetylene compound through heterogeneous catalysis | 成都理工大学 | 2023-01-31 | — | — | CN | claimed |
| CN-111518117-B | 1, 2-oxazinopyran compound and preparation method and application thereof | 西安凯新生物科技有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-111518117-A | 1, 2-oxazinopyran compound and preparation method and application thereof | 朱翠萍 | 2020-08-11 | — | — | CN | claimed |
| CN-119350362-A | Condensed ring organic compounds and their use in organic electronic devices | 广州追光科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-117164492-A | Organic semiconductor g-C 3 N 4 Method for catalytic synthesis of (E) -vinyl selenone compound | 化学与精细化工广东省实验室 | 2023-12-05 | — | — | CN | disclosed |
| CN-111518117-B | 1, 2-oxazinopyran compound and preparation method and application thereof | 西安凯新生物科技有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-110627610-B | Method for synthesizing alkyne by catalyzing asymmetric cross coupling | 南方科技大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-112939982-A | Alkyne heterocyclic BTK inhibitor and preparation method and application thereof | 药雅科技(上海)有限公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-111662313-A | Temperature-controlled molecular motor photoelectric material, preparation method and application | 南京邮电大学 | 2020-09-15 | — | — | CN | disclosed |
| CN-111518117-A | 1, 2-oxazinopyran compound and preparation method and application thereof | 朱翠萍 | 2020-08-11 | — | — | CN | disclosed |
| CN-105408340-B | Tylosin derivatives and process for their preparation | 拜耳动物保健有限责任公司 | 2020-06-12 | — | — | CN | disclosed |
| US-20160108077-A1 | TYLOSIN DERIVATIVES AND METHOD FOR PREPARATION THEREOF | THE KITASAKO INSTITUTE (JP) | 2016-04-21 | — | — | US | disclosed |
| EP-2999707-A1 | TYLOSIN DERIVATIVES AND METHOD FOR PREPARATION THEREOF | Bayer Animal Health GmbH (DE) | 2016-03-30 | — | — | EP | disclosed |
| CN-105408340-A | Tylosin derivatives and method for preparation thereof | BAYER ANIMAL HEALTH GMBH | 2016-03-16 | — | — | CN | disclosed |
| EP-1847545-B1 | SUBSTITUTED ETHYNYL GOLD-NITROGENATED HETEROCYCLIC CARBENE COMPLEX AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | UBE INDUSTRIES (JP) | 2013-03-06 | — | — | EP | disclosed |
| CN-101111499-B | Substituted ethynyl gold-nitrogen-containing heterocyclic carbene complex and organic electroluminescent device using the same | UBE INDUSTRIES | 2012-05-23 | — | — | CN | disclosed |
| US-8137821-B2 | Substituted ethynyl gold-nitrogen containing heterocyclic carbene complex and organic electroluminescent device using the same | UBE INDUSTRIES, LTD. (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20090091243-A1 | Substituted Ethynyl Gold-Nitrogen Containing Heterocyclic Carbene Complex and Organic Electroluminescent Device Using the Same | UBE INDUSTRIES, LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| CN-101111499-A | Substituted ethynyl gold-nitrogenated heterocyclic carbene complex and organic electroluminescent device using same | UBE INDUSTRIES (JP) | 2008-01-23 | — | — | CN | disclosed |
| EP-1847545-A1 | SUBSTITUTED ETHYNYL GOLD-NITROGENATED HETEROCYCLIC CARBENE COMPLEX AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | Ube Industries, Ltd. (JP) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108077-A1 | TYLOSIN DERIVATIVES AND METHOD FOR PREPARATION THEREOF | TMSB10, MLN, TMSB4X | NCF1 2364/4885LOXL2 794/4885HTR1A 1630/4885 |
| US-20090091243-A1 | Substituted Ethynyl Gold-Nitrogen Containing Heterocyclic Carbene Complex and Organic Electroluminescent Device Using the Same | ACSL3, ATXN2L, ACSL1 | NCF1 360/4885LOXL2 135/4885HTR1A 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.